甲基强的松龙和硫酸镁治疗重症支气管哮喘的疗效

Therapeutic Effect of Methylprednisolone and Magnesium Sulfate on Severe Bronchial Asthma

目的探讨甲基强的松龙和硫酸镁治疗重症支气管哮喘的疗效。方法选取我院2012年3月—2017年3月所收治的100例重症支气管哮喘患者作为研究对象。采取抽签方式,将其分为联合用药组和单一用药组,每组患者各50例。前者采取联合用药方式,即甲基强的松龙和硫酸镁治疗;后者仅采取单一用药方式,即甲基强的松龙治疗,对比两组患者的疗效。结果联合用药组在治疗总有效率及肺功能指标改善情况方面均优于单一用药组,差异具有统计学意义(P<0.05)。结论甲基强的松龙和硫酸镁治疗重症支气管哮喘的疗效确切。

Objective To investigate the efficacy of methylprednisolone and magnesium sulfate in the treatment of severe bronchial asthma. Methods A total of 100 patients with severe bronchial asthma who were treated in our hospital from March 2012 to March 2017 were selected and divided into a combination group and a single drug group. There were 50 patients in each group. The former to take methylprednisolone and magnesium sulfate combination of the way. The latter only take methylprednisolone treatment, and compared the efficacy of the two groups. Results Combined treatment group in the treatment of total effective rate and improved lung function indicators were significantly better than the single medication group （P〈0.05）. Conclusion The efficacy of methylprednisolone and magnesium sulfate in the treatment of severe bronchial asthma is definite.